ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 30 filers reported holding ANNOVIS BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wescott Financial Advisory Group, LLC | 41,607 | $1,321,000 | 0.75% |
| AIGH Capital Management LLC | 66,469 | $2,110,000 | 0.44% |
| Worth Venture Partners, LLC | 19,878 | $631,000 | 0.28% |
| Knoll Capital Management, LLC | 14,210 | $451,000 | 0.22% |
| Sterling Investment Advisors, Ltd. | 14,474 | $460,000 | 0.14% |
| Essex LLC | 11,962 | $380,000 | 0.10% |
| Redmond Asset Management, LLC | 7,878 | $250,000 | 0.08% |
| Modera Wealth Management, LLC | 33,298 | $1,057,000 | 0.05% |
| Virtus ETF Advisers LLC | 2,387 | $76,000 | 0.03% |
| Virtu Financial LLC | 11,547 | $367,000 | 0.03% |